Chr. Hansen products sweep the Food Ingredients Excellence Award board at the Food Ingredients Europe 2009 trade show.
Last night, on Nov. 17, Chr. Hansen products were awarded in two Food Ingredients Excellence Award categories at the FI Europe 2009 trade show taking place in Frankfurt, Germany this week. Award candidates represent the best and most innovative ingredients new to the market in the last two years.
Innovative cheese coagulant and outstanding meat culture
The cheese coagulant CHY-MAX® M won the “Dairy Innovation of the Year” award and the meat culture Bactoferm® Rubis was awarded the “Savoury/Meat Innovation of the Year” prize.
“Innovation is the key word of our strategy, so we are very proud that Bactoferm® Rubis has received this prestigious accolade at an important event like this,” comments Chr. Hansen’s John Jensen, Marketing Director, Meat Cultures from FI Europe.
“It’s very encouraging for Chr. Hansen to receive this recognition of CHY-MAX® M’s highly innovative qualities,” says Chr. Hansen’s David Stroo, Marketing Director, Enzymes & Tests.
Since the introduction of pre-packaged convenience food like sliced cured meat products in the supermarkets light induced oxidation has had a significant effect on the appearance and shelf-life. Packaging solutions have not solved the problem – Bactoferm® Rubis does the trick in a natural way through its ability to consume oxygen as part of its natural metabolism and without otherwise affecting the sensoric quality.
With the introduction of CHY-MAX® M Chr. Hansen shows confidence in its next generation chymosin for cheese making. Reduced costs-in-use (lower dosage, higher cheese yield), better process control, improved flavor/reduced bitterness, and increased shelf-life are some of the attractive characteristics of the product.?
For more information on the awards, go to http://fieurope.ingredientsnetwork.com/award
Chr. Hansen is at stand 8H5 in hall 8 at FI Europe.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.